Sebastián Wolf
About
In The Last Decade
Sebastián Wolf
363 papers receiving 11.0k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Ophthalmology 9.4k
- Radiology, Nuclear Medicine and Imaging 6.5k
- Molecular Biology 2.2k
- Biomedical Engineering 733
- Neurology 608
Countries citing papers authored by Sebastián Wolf
This map shows the geographic impact of Sebastián Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sebastián Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sebastián Wolf more than expected).
Fields of papers citing papers by Sebastián Wolf
This network shows the impact of papers produced by Sebastián Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sebastián Wolf. The network helps show where Sebastián Wolf may publish in the future.
Co-authorship network of co-authors of Sebastián Wolf
This figure shows the co-authorship network connecting the top 25 collaborators of Sebastián Wolf. A scholar is included among the top collaborators of Sebastián Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sebastián Wolf. Sebastián Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 13 | |
| 5 | Neovascular age-related macular degeneration (nAMD) treated with intravitreal aflibercept (IVT-AFL) treat-and-extend (T&E): post-hoc analysis of injection intensive (I-I) requirement for patients in the ARIES study | 0 |
| 6 | Comparison of treat-and-extend (T&E) dosing regimens and visual outcomes in the ARIES and ALTAIR studies of intravitreal aflibercept (IVT-AFL) in neovascular age-related macular degeneration (nAMD) | 4 |
| 7 | Efficacy of Intravitreal Aflibercept Treat-and-Extend Regimen Over 2 Years for Neovascular Age-Related Macular Degeneration: ARIES Study | 3 |
| 8 | 8 | |
| 9 | A combined phase 2a/b study of the efficacy, safety, and tolerability of repeated topical doses of regorafenib eye drops in treatment-naïve patients with neovascular age-related macular degeneration (nAMD) | 4 |
| 10 | 4 | |
| 11 | Small Dense Particles in The Retina Observable by Spectral-Domain Optical Coherence Tomography in Central Retinal Vein Occlusion | 0 |
| 12 | Detection of Chlamydia Pneumoniae and Factors of the Complement System in Neovascular Membranes of Patients With Age-Related Macular Degeneration | 1 |
| 13 | Visual Acuity Gain With Ranibizumab Therapy: Two-Year Data From the Marina, Anchor, and Pier Trials in Patients With Neovascular Amd | 2 |
| 14 | Predictive Factors for Visual Acuity of Patients With Diabetic Macular Edema Interpretated Form the Spectralis HRA+OCT (Heidelberg Engineering) | 2 |
| 15 | Fluorescein Angiographic and OCT Results From an Open–Label, Multicenter, Phase II Study Assessing the Effects of Same–Day Ranibizumab (LucentisTM) and Verteporfin PDT (Visudyne®) | 1 |
| 16 | Fundus Autofluorescence Patterns in the Junctional Zone as Prognostic Determinants for Spread of Geographic Atrophy in Age–related Macular Degeneration (AMD) | 3 |
| 17 | Quality of life in patients with age–related macular degeneration: A prospective study | 2 |
| 18 | Different types of fundus autofluorescence in patients with age–related maculopathy correlated to risk of loss of visual acuity: prospective study | 1 |
| 19 | Prospective Study for the Comparison of Two Surgical Procedures in Idiopathic Macular Hole | 1 |
| 20 | 12 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.